SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-17-004577
Filing Date
2017-01-27
Accepted
2017-01-27 16:52:46
Documents
3
Effectiveness Date
2017-01-27

Document Format Files

Seq Description Document Type Size
1 S-8 a17-3189_1s8.htm S-8 129583
2 EX-5.1 a17-3189_1ex5d1.htm EX-5.1 8082
3 EX-23.1 a17-3189_1ex23d1.htm EX-23.1 4567
  Complete submission text file 0001104659-17-004577.txt   143227
Mailing Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-215794 | Film No.: 17554412
SIC: 2836 Biological Products, (No Diagnostic Substances)